301290 东星医疗
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.8894.3896.25510.6939.896
总资产报酬率 ROA (%)0.8374.0705.6519.2497.362
投入资产回报率 ROIC (%)0.8764.3406.17910.4939.555

边际利润分析
销售毛利率 (%)47.11948.28052.27657.38055.491
营业利润率 (%)25.97326.97626.78729.04825.560
息税前利润/营业总收入 (%)24.00824.57526.42229.18226.173
净利润/营业总收入 (%)21.34023.02823.46024.87621.440

收益指标分析
经营活动净收益/利润总额(%)57.32869.86493.78893.73995.351
价值变动净收益/利润总额(%)29.75116.5072.3771.7050.839
营业外收支净额/利润总额(%)-0.3350.0491.1610.180-0.081

偿债能力分析
流动比率 (X)14.15511.4309.2093.1142.751
速动比率 (X)13.11010.6248.5892.3972.098
资产负债率 (%)4.9756.1577.55311.80913.460
带息债务/全部投入资本 (%)0.9210.4590.0710.133-0.071
股东权益/带息债务 (%)10,661.72421,503.312139,494.75373,625.961-138,046.332
股东权益/负债合计 (%)1,904.1161,519.0981,217.047739.126636.117
利息保障倍数 (X)-12.781-10.176-38.854357.15841.289

营运能力分析
应收账款周转天数 (天)93.18392.97090.42475.24595.079
存货周转天数 (天)189.511162.681163.882169.580193.059